Incidental Discovery of Synchronous Ileal Neuroendocrine Tumors at Fluorodopa PET/CT in a Patient With Bilateral Pheochromocytoma

Pheochromocytomas are tumors originating from neuroendocrine cells in the adrenal medulla, with an incidence of 0.05%. They are most often unilateral (92% of cases) and implicated in ~0.1% of hypertension cases. About 30% of pheochromocytomas are associated with hereditary syndromes such as MEN2, VHL, and NF1. When bilateral, a genetic disease is identified in 80% of patients. While coexistence of pheochromocytoma with pancreatic NETs has been described in Von Hippel-Lindau disease, coexistence of pheochromocytoma with duodenal, jejunal, or ileal NET is very rare: about 20 cases were reported in the literature, synchronous or metachronous, often associated with neurofibromatosis. We describe the case of a 58-year-old patient with a previously unremarkable history, referred to fluorodopa PET/CT for staging of a bilateral pheochromocytoma discovered in front of a typical clinical triad, who was incidentally diagnosed with 2 synchronous neuroendocrine tumors of the small bowel.

Authors

Institutions

Publication Details

Journal
Clinical Nuclear Medicine
Published
2025-07-14
DOI
https://doi.org/10.1097/rlu.0000000000006057
Primary Topic
Neuroendocrine Tumor Research Advances
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Incidental Discovery of Synchronous Ileal Neuroendocrine Tumors at Fluorodopa PET/CT in a Patient With Bilateral Pheochromocytoma

Mathilde Funes de la Vega, Clément Drouet, A. Darras, Elodie Crevisy
Clinical Nuclear Medicine
Neuroendocrine Tumor Research Advances
article

Incidental Discovery of Synchronous Ileal Neuroendocrine Tumors at Fluorodopa PET/CT in a Patient With Bilateral Pheochromocytoma

Mathilde Funes de la Vega, Clément Drouet, A. Darras, Elodie Crevisy
article en

Abstract

Pheochromocytomas are tumors originating from neuroendocrine cells in the adrenal medulla, with an incidence of 0.05%. They are most often unilateral (92% of cases) and implicated in ~0.1% of hypertension cases. About 30% of pheochromocytomas are associated with hereditary syndromes such as MEN2, VHL, and NF1. When bilateral, a genetic disease is identified in 80% of patients. While coexistence of pheochromocytoma with pancreatic NETs has been described in Von Hippel-Lindau disease, coexistence of pheochromocytoma with duodenal, jejunal, or ileal NET is very rare: about 20 cases were reported in the literature, synchronous or metachronous, often associated with neurofibromatosis. We describe the case of a 58-year-old patient with a previously unremarkable history, referred to fluorodopa PET/CT for staging of a bilateral pheochromocytoma discovered in front of a typical clinical triad, who was incidentally diagnosed with 2 synchronous neuroendocrine tumors of the small bowel.

Clinical Nuclear MedicineVol. 51(4)
Centre Georges François Leclerc (FR)
Good health and well-being
Openalex Percentile: Top 75%
Neuroendocrine Tumor Research Advances
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Incidental Discovery of Synchronous Ileal Neuroendocrine Tumors at Fluorodopa PET/CT in a Patient With Bilateral Pheochromocytoma — Mathilde Funes de la Vega, Clément Drouet, et al. · Clinical Nuclear Medicine (2025) | TGRS Research Map | TGRS